Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-01-31

FDA Approved: MESALAMINE — Supplemental Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Camber Pharmaceuticals' supplemental application for mesalamine (generic), approving changes to an existing approved product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mesalamine (Mesalamine)

Snippet

SUPPL AP for MESALAMINE (MESALAMINE)